{"pmid":32250482,"title":"Mitigating and learning from the impact of COVID-19 infection on addictive disorders.","text":["Mitigating and learning from the impact of COVID-19 infection on addictive disorders.","Addiction","Marsden, John","Darke, Shane","Hall, Wayne","Hickman, Matt","Holmes, John","Humphreys, Keith","Neale, Joanne","Tucker, Jalie","West, Robert","32250482"],"journal":"Addiction","authors":["Marsden, John","Darke, Shane","Hall, Wayne","Hickman, Matt","Holmes, John","Humphreys, Keith","Neale, Joanne","Tucker, Jalie","West, Robert"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250482","week":"202015|Apr 06 - Apr 12","doi":"10.1111/add.15080","keywords":["COVID-19","addictive disorders","public health","research","treatment"],"source":"PubMed","weight":0,"_version_":1663352136225783808,"score":7.6679378,"similar":[{"pmid":32093211,"pmcid":"PMC7074453","title":"Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.","text":["Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.","In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible.","J Clin Med","Deng, Sheng-Qun","Peng, Hong-Juan","32093211"],"abstract":["In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible."],"journal":"J Clin Med","authors":["Deng, Sheng-Qun","Peng, Hong-Juan"],"date":"2020-02-26T11:00:00Z","year":2020,"_id":"32093211","week":"20209|Feb 24 - Mar 01","doi":"10.3390/jcm9020575","keywords":["2019-nCoV","COVID-19","SARS-CoV-2","clinical characteristics","coronavirus","diagnosis","pneumonia","prevention and control","public health","treatment"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Prevention","Diagnosis"],"weight":1,"_version_":1663352134504022016,"score":64.97876},{"pmid":32240293,"title":"Collision of the COVID-19 and Addiction Epidemics.","text":["Collision of the COVID-19 and Addiction Epidemics.","Ann Intern Med","Volkow, Nora D","32240293"],"journal":"Ann Intern Med","authors":["Volkow, Nora D"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240293","week":"202014|Mar 30 - Apr 05","doi":"10.7326/M20-1212","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135572520960,"score":51.97425},{"pmid":32250460,"title":"Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders.","text":["Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders.","Mov Disord","Papa, Stella M","Brundin, Patrik","Fung, Victor S C","Kang, Un Jung","Burn, David J","Colosimo, Carlo","Chiang, Han-Lin","Alcalay, Roy N","Trenkwalde, Claudia","32250460"],"journal":"Mov Disord","authors":["Papa, Stella M","Brundin, Patrik","Fung, Victor S C","Kang, Un Jung","Burn, David J","Colosimo, Carlo","Chiang, Han-Lin","Alcalay, Roy N","Trenkwalde, Claudia"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250460","week":"202015|Apr 06 - Apr 12","doi":"10.1002/mds.28067","keywords":["COVID-19","Coronavirus","Movement Disorders","Pandemic","Parkinson's Disease","SARS-CoV-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352136271921153,"score":45.931007},{"pmid":32207676,"title":"2019-ncov's epidemic in middle province of northern Italy: impact, logistic & strategy in the first line hospital.","text":["2019-ncov's epidemic in middle province of northern Italy: impact, logistic & strategy in the first line hospital.","The novel coronavirus (2019-nCoV) began in China in early December 2019 and rapidly has spread to many countries around the globe, with the number of confirmed cases increasing every day. An epidemic has been recorded since February 20 in a middle province in Northern Italy (Lodi's province, in the low Po Valley). The first line Hospital had to redesign its logistical and departmental structure to respond to the influx of 2019-ncov positive patients who needed hospitalisation. Logistical and structural strategies were guided by the crisis unit, managing in 8 days from the beginning of the epidemic to prepare the hospital ready to welcome more than 200 positive COVID19 patients with different ventilatory requirements, keeping clean emergency access lines and restoring surgical interventions and deferred urgent ordinary activity.","Disaster Med Public Health Prep","Gagliano, Annalisa","Villani, Pier Giorgio","Co, Francesca M","Paglia, Stefano","Bisagni, Pietro A G","Perotti, Gabriele M","Storti, Enrico","Lombardo, Massimo","32207676"],"abstract":["The novel coronavirus (2019-nCoV) began in China in early December 2019 and rapidly has spread to many countries around the globe, with the number of confirmed cases increasing every day. An epidemic has been recorded since February 20 in a middle province in Northern Italy (Lodi's province, in the low Po Valley). The first line Hospital had to redesign its logistical and departmental structure to respond to the influx of 2019-ncov positive patients who needed hospitalisation. Logistical and structural strategies were guided by the crisis unit, managing in 8 days from the beginning of the epidemic to prepare the hospital ready to welcome more than 200 positive COVID19 patients with different ventilatory requirements, keeping clean emergency access lines and restoring surgical interventions and deferred urgent ordinary activity."],"journal":"Disaster Med Public Health Prep","authors":["Gagliano, Annalisa","Villani, Pier Giorgio","Co, Francesca M","Paglia, Stefano","Bisagni, Pietro A G","Perotti, Gabriele M","Storti, Enrico","Lombardo, Massimo"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32207676","week":"202013|Mar 23 - Mar 29","doi":"10.1017/dmp.2020.51","keywords":["2019-ncov","emergency","public health","strategy"],"source":"PubMed","locations":["Italy","China","middle"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663352133698715651,"score":43.24794}]}